Department of
The ASOS-2 project was a response to the findings in ASOS-1, that African surgical patients are twice as likely to die in the hospital after surgery than the international average. The project aimed to shift the limited existing resources available for postoperative surveillance towards those patients at higher risk of developing postoperative complications.
Funded by a $33 million grant from the Patient-Centered Outcomes Research Institute (PCORI), a new study led by Michael Avidan, MBBCh, of Washington University School of Medicine in St. Louis and Sachin Kheterpal, MD, of the University of Michigan, will compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.
The Daniel X. Freedman Award is given for outstanding achievements in basic research by a Brain & Behavior Research Foundation Young Investigator and honors outstanding scientists working to advance the prevention, diagnosis and treatment of psychiatric illness.
Wayland Cheng, MD, PhD has been selected as the 2021 recipient of the prestigious Frontiers in Anesthesia Research Award (FARA) from the International Anesthesia Research Society (IARS).
Dr. Baron Chanda received a grant from the NINDS to to study cells’ ion channels as potential targets for new drugs to treat disorders affecting the brain, heart and muscles.
The department received over $16.1 million in federal funding from the NIH, and six faculty ranked in the top 50 for total NIH funding to individual anesthesia principal investigators.
The ASSURE fellowship program will provide college students from the St. Louis metro area an opportunity to engage in basic, clinical, and/or translational research projects.
Ro Sandoval, research technician in the Moron-Concepcion Lab, was recently recognized by the Society for the Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS).
Dr. Evers will serve as the Interim Director of the Center for Clinical Pharmacology (CCP) as leadership looks to recruit a dynamic and visionary Center Director.
Dr. Moron-Concepcion’s presentation will focus on how persistent pain alters the rewarding and motivational properties of opioids and will highlight the work of the research being conducted in the department.